Cerebrospinal Fluid Biomarkers in Clinical Subtypes of Early-Onset Alzheimer's Disease

Dementia and Geriatric Cognitive Disorders - Switzerland
doi 10.1159/000355555
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

Cerebrospinal Fluid Tau and Phosphotau as Biomarkers in Alzheimer's Disease Diagnosis

Basic and Clinical Neuroscience
Molecular NeuroscienceNeurologyCellular
2019English

Disease Biomarkers in Cerebrospinal Fluid of Patients With First-Onset Psychosis

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2006English

Cerebrospinal Fluid Neurogranin and YKL-40 as Biomarkers of Alzheimer's Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2015English

Early-Onset Alzheimer's Disease: Nonamnestic Subtypes and Type 2 AD

Archives of Medical Research
Medicine
2012English

Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms

Neurodegenerative Diseases
Neurology
2013English

Relations Between Personality Changes and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology

Journal of Psychiatric Research
PsychiatryBiological PsychiatryMental Health
2017English

Early Onset Alzheimer's Disease

MOJ Gerontology & Geriatrics
2018English

Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer's Disease

2019English

Regionally Specific Changes in the Hippocampal Circuitry Accompany Progression of Cerebrospinal Fluid Biomarkers in Preclinical Alzheimer's Disease

Human Brain Mapping
Nuclear MedicineRadiologyUltrasound TechnologyAnatomyRadiologicalNeurologyImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy